Get the Stockscreener App
33.20
4.30%
1.37
After Hours:
33.27
0.07
+0.21%
Nanobiotix Adr stock is traded at $33.20, with a volume of 68,263.
It is up +4.30% in the last 24 hours and up +0.39% over the past month.
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
See More
Previous Close:
$31.83
Open:
$32.51
24h Volume:
68,263
Relative Volume:
1.42
Market Cap:
$1.61B
Revenue:
$32.72M
Net Income/Loss:
$-27.55M
P/E Ratio:
-58.06
EPS:
-0.5718
Net Cash Flow:
$-41.40M
1W Performance:
+7.76%
1M Performance:
+0.39%
6M Performance:
+19.47%
1Y Performance:
+873.61%
1-Day Range:
$32.48
$33.79
1-Week Range:
$29.36
$33.86
52-Week Range:
$3.1178
$41.89
Nanobiotix Adr Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
33.20 | 1.54B | 32.72M | -27.55M | -41.40M | -0.5718 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-26 | Initiated | TD Cowen | Buy |
| Aug-28-24 | Initiated | Guggenheim | Buy |
| Dec-08-23 | Initiated | Leerink Partners | Outperform |
| Jan-06-21 | Initiated | Evercore ISI | Outperform |
Nanobiotix Adr Stock (NBTX) Latest News
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix H2 Earnings Call Highlights - Yahoo Finance
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - ChartMill
Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process - Benzinga
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
Nanobiotix (NASDAQ:NBTX) Shares Gap UpShould You Buy? - MarketBeat
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
Nanobiotix (NASDAQ:NBTX) Shares Gap DownWhat's Next? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up Following Analyst Upgrade - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Gap Up After Analyst Upgrade - MarketBeat
Nanobiotix (NASDAQ:NBTX) Stock Price Up 5.8% – Here’s What Happened - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5.8%Should You Buy? - MarketBeat
Looking Into Nanobiotix SA's Recent Short Interest - Sahm
Nanobiotix (NASDAQ:NBTX) Stock Price Down 6.2%Here's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Trading Up 3.3% – Time to Buy? - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 3.3%Time to Buy? - MarketBeat
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5%What's Next? - MarketBeat
Preferred dividends of Nanobiotix SA Sponsored ADR – LS:A2QKZM - TradingView
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives $11.00 Consensus Price Target from Analysts - Defense World
Leerink Partnrs Decreases Earnings Estimates for Nanobiotix - Defense World
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer - MSN
Nanobiotix Adr Stock (NBTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):